Masked Hypertension in Diabetes Mellitus Treatment Implications for Clinical Practice

Stanley S. Franklin, Lutgarde Thijs, Yan Li, Tine W. Hansen, Jose Boggia, Yanping Liu, Kei Asayama, Kristina Bjorklund-Bodegard, Takayoshi Ohkubo, Jorgen Jeppesen, Christian Torp-Pedersen, Eamon Dolan, Tatiana Kuznetsova, Katarzyna Stolarz-Skrzypek, Valerie Tikhonoff, Sofia Malyutina, Edoardo Casiglia, Yuri Nikitin, Lars Lind, Edgardo SandoyaKalina Kawecka-Jaszcz, Jan Filipovsky, Yutaka Imai, Jiguang Wang, Hans Ibsen, Eoin O'Brien, Jan A. Staessen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Although distinguishing features of masked hypertension in diabetics are well known, the significance of antihypertensive treatment on clinical practice decisions has not been fully explored. We analyzed 9691 subjects from the population-based 11-country International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes. Prevalence of masked hypertension in untreated normotensive participants was higher (P
Original languageEnglish
Pages (from-to)964–971
Issue number5
Publication statusPublished - May 2013


  • ambulatory blood pressure
  • conventional blood pressure
  • diabetes mellitus
  • masked hypertension
  • population study


Dive into the research topics of 'Masked Hypertension in Diabetes Mellitus Treatment Implications for Clinical Practice'. Together they form a unique fingerprint.

Cite this